But many GLP-1 users do not want another comparison point
Clinical trials, including the SURMOUNT-5 study, demonstrate tirzepatides ability to achieve 13.7-20.2% weight loss in individuals with obesity but without type 2 diabetes, outperforming other GLP-1 receptor agonists in direct comparisons
These include potential heart disease, kidney damage and nerve issues
Discussions were first embedded into a numerical representation using a pretrained, document-level Bidirectional Encoder Representations from Transformers (BERT)-like architecture model called Beijing Academy of Artificial Intelligence (BAAI) Generalized Embeddings (bge-base-en-v1.5) 7 , which is trained over an extensive text corpus on both supervised and unsupervised techniques to achieve state-of-the-art performance on the Massive Text Embedding Benchmark 8
FDA (2024)
Bifidobacteria are early colonisers of the infant gut and produce SCFAs, like acetate and lactate, which cross-feed other gut inhabitants, including butyrate producers, such as Faecalibacterium prausnitzii
